SeekInCure™
Pan-cancer Recurrence monitoring
SeekInCureTM is the first-in-class blood-based pan-cancer recurrence monitoring test.
A panoramic view of cancer genomic landscape
cfDNA detection via NGS builds cacer genomic landscape view
Cutting-edge multivariate algrithm
Genomics combines with proteomics，capture the signal of cancer recurrence
Multidimensional fingerprint
CNA、Fragmentation and protein markers discover the law of cancer molecule recurrence
Big date and Artificial intelligence
CRI model constructed by machine learning evaluates the risk of cancer recurrence precisely
Specifications
Indicated subjects: cancer patients amendable to radical resection
Sample requirement: 10ml post-op peripheral bloodTAT：10 working days
Results readout: CRI (cancer recurrence index)
Sampling time:
粤公网安备 44030802000447号所有文章
×